Clinical Trials
2 trialsNCT06314087 2025-03-25
Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)
The University of Hong Kong-Shenzhen Hospital
Phase 2 Recruiting
NCT05061628 2021-09-29
The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Unknown